Meetings & Agendas
Recommendations for review topics and comments and suggestions about the Nebraska Medicaid DUR program can be directed to Nebraska DUR Director, Marcia Mueting, PharmD, RP, at 402-420-1500.
Meeting agendas are posted to the website 30 days prior to the scheduled meeting. From the date that the agenda is posted until after the DUR Board meeting is held, it is inappropriate for anyone receiving compensation from a pharmaceutical manufacturer, to contact a Board member regarding DUR Board agenda items. If a Board Member is contacted by anyone receiving compensation from a pharmaceutical manufacturer, no public comment will be allowed on that manufacturer’s agenda item during that DUR Board meeting. If a DUR Board Member is contacted about an agenda item, it shall be reported to the DUR Director.
DUR Board meetings are open to the public for attendance. Guidelines for public comment at DUR Board meetings include:
- Unsolicited presentations are limited to 5 minutes per drug or topic, regardless of the number of presenters and time will be evenly divided among presenters.
- Written materials may be distributed to DUR Board members if 20 copies are supplied to the Director 15 days prior to the scheduled meeting.